Sign Out
The usual initial dosage is one tablet of Telmisartan/Hydrochlorothiazide (Telxibloc) daily. A patient whose blood pressure is not adequately controlled with Telmisartan monotherapy 40 mg may be switched to Telmisartan/Hydrochlorothiazide (Telxibloc). The dose may be increased, if necessary, to two tablets of Telmisartan/Hydrochlorothiazide (Telxibloc) daily. Telmisartan/Hydrochlorothiazide (Telxibloc) may be administered with other antihypertensive agents. It may be administered with or without food. The combination may be substituted for the titrated components.
Patients with Hepatic Impairment: Telmisartan/Hydrochlorothiazide (Telxibloc) is not recommended for patients with severe hepatic impairment. Patients with biliary obstructive disorders or hepatic impairment should have treatment started under close medical supervision.
Continue with Google